NVRO
$116.67
Nevro
$.05
.04%
NVRO
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.86)
Revenue:  $116.77 Mil
Monday
Nov 8
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when NVRO reports earnings?
Beat
Meet
Miss

Where is NVRO's stock price going from here?
Up
Flat
Down
Stock chart of NVRO
Analysts
Summary of analysts' recommendations for NVRO
Score
Grade
Pivots
Resistance
$120.63
$119.77
$118.22

$117.36

Support
$115.81
$114.95
$113.40
Tweet
Growth
Description
Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza (R) spinal cord stimulation (SCS) system for the treatment of chronic pain. Senza, HF10, Nevro and the Nevro logo are trademarks of the company. Nevro Corp. is headquartered in Menlo Park, California.
Peers
MedtronicCONMED